Search

everythinglearnresearchcommunity

for

Search:↓

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Pilonidal sinus disease is linked to more severe hidradenitis suppurativa.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

People with certain skin diseases often have more trouble understanding and describing their emotions, which can affect their health and treatment results.

Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.

Insulin resistance linked to obesity may increase COVID-19 severity.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

Anabolic steroid users may face higher risk of severe COVID-19.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Vitiligo patients are willing to pay the most for treatment, regardless of disease severity.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Patients with autoimmune blistering diseases experience a reduced quality of life, with the need for better measurement tools, especially for those with mucous membrane pemphigoid.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

Some COVID-19 pneumonia patients in Veracruz, Mexico had rare skin issues like temporary hair loss linked to disease severity.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

Japanese researchers created new hair follicles from human cells that grew hair when put into mice, and other findings showed a link between eye disease severity and corneal thickness, gene mutations affecting hearing and touch, and the safety of the shingles vaccine for adults over 50.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.